EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MIC

Cristina Villellas iD, Frederik Stevenaert iD, Bart Remmerie, Koen Andries

Antimicrobial Agents and Chemotherapy · 03.04.2024 · 68 (4)

DOI: 10.1128/aac.01275-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.04.2024. Verfasst von Cristina Villellas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Research and Development, Beerse, Belgium. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug-resistant tuberculosis (MDR-TB) patients not cured at the time of stopping treatment are exposed to Minimum Inhibitory Concentration (MIC) and sub-MIC levels for many months after discontinuing bedaquiline (BDQ) or clofazimine (CFZ) treatment. In vitro cultures treated with BDQ and CFZ sub-MIC concentrations clearly showed enrichment in the Rv0678 mutant population, demonstrating that pre-existing Rv0678 mutants can be selected by sub-MIC concentrations of BDQ and CFZ if not protected by an alternative MDR-TB treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantHumansClofazimineAntitubercular AgentsDiarylquinolinesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Rv0678bedaquilineclofaziminedrug resistancetuberculosis

Substanzen

ClofaziminebedaquilineAntitubercular AgentsDiarylquinolines

Autor:innen und Institutionen

  • Janssen Research and Development, Beerse, Belgium.

ORCID-Profile: Cristina Villellas, Frederik Stevenaert

Zitieren

APA

Villellas, C., Stevenaert, F., Remmerie, B., & Andries, K. (2024). Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MIC. Antimicrobial Agents and Chemotherapy, 68(4). https://doi.org/10.1128/aac.01275-23

Vancouver

Villellas C, Stevenaert F, Remmerie B, Andries K. Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MIC. Antimicrobial Agents and Chemotherapy. 2024;68(4). doi:10.1128/aac.01275-23

BibTeX
@article{Villellas2024,
  author = {Villellas, Cristina and Stevenaert, Frederik and Remmerie, Bart and Andries, Koen},
  title = {Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MIC},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {4},
  doi = {10.1128/aac.01275-23}
}
Kostenlos starten →